{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:45:31Z","timestamp":1789008331071,"version":"build-2803163510"},"reference-count":27,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":211,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The gender, age, alpha-fetoprotein (AFP), and des-gamma-carboxy prothrombin (GAAD) score is a recent predictive tool for hepatocellular carcinoma (HCC) but lacks comparison with the AFP, Sex, Age, and Protein induced by vitamin K absence-II (ASAP) score, which uses similar parameters with different assays and formulas. Our study aimed to evaluate the performance differences between these two scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Blood samples from 622 patients with chronic liver diseases at Songklanagarind Hospital between 20 April 2023 and 31 December 2023 were analyzed. The cutoffs for the ASAP and GAAD scores were established as 0.526 and 2.570, respectively, and HCC diagnoses followed the European Association for the Study of the Liver (EASL) or the American Association for the Study of Liver Diseases (AASLD) guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HCC diagnoses were observed in 28.6% of patients, with 48.3% diagnosed with early-stage diseases (Barcelona Clinic Liver Cancer stage 0\u2009=\u200923, A\u2009=\u200963). Hepatitis B virus infection (40.4%) and metabolic dysfunction-associated steatotic liver disease (21.3%) were predominant causes. The area under the receiver operating characteristic curve (AUROCs) of the ASAP and GAAD scores for predicting all-stage HCC were comparable (0.933 vs 0.937, P\u2009=\u20090.578). For early-stage HCC, AUROCs were 0.880 (ASAP) and 0.891 (GAAD) (P\u2009=\u20090.353). Sensitivity and specificity for predicting all-stage HCC were 83.15% and 91.44% (ASAP), and 82.58% and 89.64% (GAAD), respectively; these values for early-stage HCC were 66.28% and 91.44% (ASAP) and 67.44% and 89.64% (GAAD). Subgroup analyses by cirrhosis and etiology showed no significant differences. New cutoff values of \u22120.083 (ASAP) and 1.725 (GAAD) were identified for at least 80% sensitivity and specificity for predicting early-stage HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both the GAAD and ASAP scores demonstrated excellent and comparable abilities in HCC detection across all stages, unaffected by cirrhosis or etiological differences.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/gastro\/goaf074","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T14:08:32Z","timestamp":1752502112000},"source":"Crossref","is-referenced-by-count":8,"title":["Comparative performance of the GAAD and ASAP scores in predicting early-stage hepatocellular carcinoma"],"prefix":"10.1093","volume":"13","author":[{"given":"Chongkonrat","family":"Maneenil","sequence":"first","affiliation":[{"name":"Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University , Songkhla,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pimsiri","family":"Sripongpun","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University , Songkhla,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naichaya","family":"Chamroonkul","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University , Songkhla,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piraya","family":"Tantisaranon","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Prince of Songkla University , Songkhla,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roongrueng","family":"Jarumanokul","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Prince of Songkla University , Songkhla,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maseetoh","family":"Samaeng","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University , Songkhla,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupawadee","family":"Yamsuwan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Prince of Songkla University , Songkhla,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalita","family":"Fonghoi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Prince of Songkla University , Songkhla,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amornkan","family":"Numit","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Prince of Songkla University , Songkhla,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerha","family":"Piratvisuth","sequence":"additional","affiliation":[{"name":"NKC Institute of Gastroenterology and Hepatology, Faculty of Medicine, Prince of Songkla University , Songkhla,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4058-5977","authenticated-orcid":false,"given":"Apichat","family":"Kaewdech","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University , Songkhla,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"2025081215095548500_goaf074-B1","doi-asserted-by":"crossref","first-page":"e00310","DOI":"10.14309\/ctg.0000000000000310","article-title":"Validation of the \u2018six-and-twelve\u2019 prognostic score in transarterial chemoembolization-treated hepatocellular carcinoma patients","volume":"12","author":"Kaewdech","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"2025081215095548500_goaf074-B2","doi-asserted-by":"crossref","first-page":"19544","DOI":"10.1038\/s41598-024-70526-z","article-title":"Changes in the epidemiological trends of primary liver cancer in the Asia-Pacific region","volume":"14","author":"Danpanichkul","year":"2024","journal-title":"Sci Rep"},{"key":"2025081215095548500_goaf074-B3","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2025081215095548500_goaf074-B4","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"key":"2025081215095548500_goaf074-B5","first-page":"294","article-title":"Epidemiology and treatment of hepatocellular carcinoma in Thailand","volume":"47","author":"Chonprasertsuk","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"2025081215095548500_goaf074-B6","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/liv.15251","article-title":"Changing epidemiology of hepatocellular carcinoma in Asia","volume":"42","author":"Zhang","year":"2022","journal-title":"Liver Int"},{"key":"2025081215095548500_goaf074-B7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"2025081215095548500_goaf074-B8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J Hepatol"},{"key":"2025081215095548500_goaf074-B9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"2025081215095548500_goaf074-B10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/v17010034","article-title":"Asian perspective on hepatitis B virus and hepatitis C virus elimination","volume":"17","author":"Kaewdech","year":"2024","journal-title":"Viruses"},{"key":"2025081215095548500_goaf074-B11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"2025081215095548500_goaf074-B12","doi-asserted-by":"crossref","first-page":"goaf045","DOI":"10.1093\/gastro\/goaf045","article-title":"Current and new strategies for hepatocellular carcinoma surveillance","volume":"13","author":"Polpichai","year":"2025","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"2025081215095548500_goaf074-B13","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"2025081215095548500_goaf074-B14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2022.01.023","article-title":"HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis","volume":"77","author":"Singal","year":"2022","journal-title":"J Hepatol"},{"key":"2025081215095548500_goaf074-B15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cgh.2019.11.012","article-title":"GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis","volume":"18","author":"Best","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025081215095548500_goaf074-B16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.32185","article-title":"GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis","volume":"75","author":"Singal","year":"2022","journal-title":"Hepatology"},{"key":"2025081215095548500_goaf074-B17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/ph14080735","article-title":"GALAD score detects early-stage hepatocellular carcinoma in a European cohort of chronic hepatitis B and C patients","volume":"14","author":"Schotten","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"2025081215095548500_goaf074-B18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1158\/1055-9965.EPI-18-0281","article-title":"GALAD score for hepatocellular carcinoma detection in comparison with liver ultrasound and proposal of GALADUS score","volume":"28","author":"Yang","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025081215095548500_goaf074-B19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/1055-9965.EPI-13-0870","article-title":"The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers","volume":"23","author":"Johnson","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025081215095548500_goaf074-B20","doi-asserted-by":"crossref","first-page":"e0317","DOI":"10.1097\/HC9.0000000000000317","article-title":"Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies","volume":"7","author":"Piratvisuth","year":"2023","journal-title":"Hepatol Commun"},{"key":"2025081215095548500_goaf074-B21","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1373\/clinchem.2019.308965","article-title":"A novel online calculator based on serum biomarkers to detect hepatocellular carcinoma among patients with hepatitis B","volume":"65","author":"Yang","year":"2019","journal-title":"Clin Chem"},{"key":"2025081215095548500_goaf074-B22","doi-asserted-by":"crossref","first-page":"1018396","DOI":"10.3389\/fonc.2022.1018396","article-title":"ASAP score versus GALAD score for detection of hepatitis C-related hepatocellular carcinoma: a multicenter case-control analysis","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"2025081215095548500_goaf074-B23","doi-asserted-by":"crossref","first-page":"S937","DOI":"10.1016\/S0168-8278(22)02154-7","article-title":"A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early-stage hepatocellular carcinoma in an international cohort","volume":"77","author":"Chan","year":"2022","journal-title":"J Hepatol"},{"key":"2025081215095548500_goaf074-B24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","article-title":"Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"23","author":"Tan","year":"2022","journal-title":"Lancet Oncol"},{"key":"2025081215095548500_goaf074-B25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/apt.13841","article-title":"Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"45","author":"Simmons","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2025081215095548500_goaf074-B26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jhep.2023.02.022","article-title":"International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance","volume":"79","author":"Singal","year":"2023","journal-title":"J Hepatol"},{"key":"2025081215095548500_goaf074-B27","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.3390\/jcm13226770","article-title":"Beyond the liver: a comprehensive review of strategies to prevent hepatocellular carcinoma","volume":"13","author":"Polpichai","year":"2024","journal-title":"J Clin Med"}],"container-title":["Gastroenterology Report"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/gastro\/article-pdf\/doi\/10.1093\/gastro\/goaf074\/63897567\/goaf074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/gastro\/article-pdf\/doi\/10.1093\/gastro\/goaf074\/63897567\/goaf074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T19:10:04Z","timestamp":1755025804000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/gastro\/article\/doi\/10.1093\/gastro\/goaf074\/8219717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1093\/gastro\/goaf074","relation":{},"ISSN":["2052-0034"],"issn-type":[{"value":"2052-0034","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"goaf074"}}